Amylyx Pharmaceuticals Announces $350.0 Million Proposed Public Offering of Common StockBusiness Wire•18/08/2026•16:01 ET0 ShareWhiz InsightsGenerateGet startedCreate a free account to read the full story.Sign UpAlready have an account? Log inForgot password?
